Top

BMC Musculoskeletal Disorders

Published in:

Open Access 01-12-2019 | Osteoarthrosis | Research article

Use of prescription analgesic drugs before and after hip or knee replacement in patients with osteoarthritis

Authors: Tuomas J. Rajamäki Jr, Pia A. Puolakka, Aki Hietaharju, Teemu Moilanen, Esa Jämsen

Published in: BMC Musculoskeletal Disorders | Issue 1/2019

Abstract

Background

Analgesic drugs are recommended to treat pain caused by osteoarthritis, and joint replacement should decrease the need for them. We aimed to determine the user rates of analgesic drugs before and after joint replacement.

Methods

All patients who underwent a primary hip or knee replacement for osteoarthritis from 2002 to 2013 in a region of 0.5 million people were identified. Patients with revision or other joint replacements during the study period (operation date +/− two years) were excluded, leaving 6238 hip replacements (5657 patients) and 7501 knee replacements (6791 patients) for analyses. Medication data were collected from a nationwide Drug Prescription Register and the prevalence (with its 95% confidence intervals) of acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), mild opioids, strong opioids, and medications used for neuropathic pain was calculated in three-month periods two years before and after surgery.

Results

Between two years and three months preoperatively, the proportion of patients who redeemed at least one type of analgesic drug increased from 28% (95% CI, 27–30%) to 48% (47–50%) on hip replacement patients and from 33% (32–34%) to 41% (40–42%) on knee replacement patients. Postoperatively, the proportions decreased to 23% (22–24%) on hip and to 30% (29–31%) on knee patients. Hip replacement patients used more NSAIDs (34% (32–35%) hip vs 26% (25–27%) knee, p < 0.001), acetaminophen (14% (13–15%) vs 12% (11–13%), p < 0.001), and mild opioids (14% (13–15%) vs 9% (8–9%), p < 0.001) than knee patients preoperatively, but postoperatively hip patients used less NSAIDs (12% (11–13%) vs 16% (15–16%), p < 0.001), acetaminophen (9% (8–10%) vs 11% (11–12%), p < 0.001), and mild opioids (5% (5–6%) vs 8% (7–8%), p < 0.001).

Conclusion

Use of analgesic drugs increases prior to joint replacement, and is reduced following surgery. However, a considerable proportion of patients continue to use analgesics in two-year follow-up.

Available only for authorised users

Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil [Internet]. 2010;18(4):476–99 Available from: https://doi.org/10.1016/j.joca.2010.01.013.CrossRef

Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) [Internet]. 2012;64(4):465–74 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22563589.CrossRef

Larmer PJ, Reay ND, Aubert ER, Kersten P. Systematic review of guidelines for the physical Management of Osteoarthritis. Arch Phys Med Rehabil [Internet]. 2014;95(2):375–89 Available from: http://linkinghub.elsevier.com/retrieve/pii/S0003999313011052.CrossRef

National Institute for Health and Clinical Excellence. NICE guideline on osteoarthritis: The care and management of osteoarthritis in adults, NICE clinical guideline 177, 2014. Online document at: http://guidance.nice.org.uk/CG177 Accessed February 19, 20. Available from: https://www.nice.org.uk/guidance/cg59

Working group set up by the Finnish Medical Society Duodecim and the Finnish Orthopaedic Association. Knee and hip osteoarthritis (online). Current care guidelines. Helsinki: The Finnish Medical Society Duodecim, 2012 (referred April 13, 2018). Available.

Carr AJ, Robertsson O, Graves S, Price AJ, Arden NK, Judge A, et al. Knee replacement. Lancet (London, England) [Internet] 2012 [cited 2017 Jan 23];379(9823):1331–1340. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673611607526 CrossRef

Shan L, Shan B, Graham D, Saxena A. Total hip replacement: a systematic review and meta-analysis on mid-term quality of life. Osteoarthr Cartil [Internet]. 2014;22(3):389–406 Available from: http://linkinghub.elsevier.com/retrieve/pii/S106345841301039X.CrossRef

Shan L, Shan B, Suzuki A, Nouh F, Saxena A. Intermediate and long-term quality of life after Total knee replacement. J Bone Jt Surg [Internet]. 2015;97(2):156–68 Available from: http://insights.ovid.com/crossref?an=00004623-201501210-00010.CrossRef

Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open [Internet]. 2012;2(1):e000435 Available from: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2011-000435. CrossRef

10.

Kingsbury SR, Hensor EMA, Walsh CAE, Hochberg MC, Conaghan PG. How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the osteoarthritis initiative. Arthritis Res Ther [Internet]. 2013;15(5):R106 Available from: http://arthritis-research.biomedcentral.com/articles/10.1186/ar4286.CrossRef

11.

Fuzier R, Serres I, Bourrel R, Palmaro A, Montastruc J-L, Lapeyre-Mestre M. Analgesic drug consumption increases after knee arthroplasty: A pharmacoepidemiological study investigating postoperative pain. Pain [Internet]. 2014 [cited 2018 Apr 14];155(7):1339–1345. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006396-201407000-00024

12.

Dusad A, Pedro S, Mikuls TR, Hartman CW, Garvin KL, O’Dell JR, et al. Impact of Total knee arthroplasty as assessed using patient-reported pain and health-related quality of life indices: rheumatoid arthritis versus osteoarthritis. Arthritis Rheumatol [Internet]. 2015;67(9):2503–11 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26213106.CrossRef

13.

Blågestad T, Nordhus IH, Grønli J, Engesæter LB, Ruths S, Ranhoff AH, et al. Prescription trajectories and effect of total hip arthroplasty on the use of analgesics, hypnotics, antidepressants, and anxiolytics. Pain [Internet]. 2016 [cited 2018 Apr 14];157(3):643–651. Available from: https://insights.ovid.com/crossref?an=00006396-201603000-00016

14.

Inacio MCS, Cashman K, Pratt NL, Gillam MH, Caughey G, Graves SE, et al. Prevalence and changes in analgesic medication utilisation 1 year prior to total joint replacement in an older cohort of patients. Osteoarthr Cartil [Internet]. 2018;26(3):356–62 Available from: https://doi.org/10.1016/j.joca.2017.11.016.CrossRef

15.

Jørgensen CC, Petersen M, Kehlet H, Aasvang EK. Analgesic consumption trajectories in 8975 patients 1 year after fast-track total hip or knee arthroplasty. Eur J Pain. 2018;22(April):1428–38.CrossRef

16.

Goesling J, Moser SE, Zaidi B, Hassett AL, Hilliard P, Hallstrom B, et al. Trends and predictors of opioid use after total knee and total hip arthroplasty. Pain [Internet]. 2016 Jun [cited 2018 Apr 14];157(6):1259–1265. Available from: https://insights.ovid.com/crossref?an=00006396-201606000-00012

17.

Hansen CA, Inacio MCS, Pratt NL, Roughead EE, Graves SE. Chronic use of opioids before and after Total knee arthroplasty: a retrospective cohort study. J Arthroplast [Internet]. 2017;32(3):811–817.e1 Available from: https://doi.org/10.1016/j.arth.2016.09.040.CrossRef

18.

Inacio MCS, Hansen C, Pratt NL, Graves SE, Roughead EE. Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open [Internet]. 2016;6(4):e010664 Available from: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2015-010664.CrossRef

19.

Singh JA, Lewallen D. Predictors of pain and use of pain medications following primary Total hip arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years. BMC Musculoskelet Disord [Internet]. 2010[cited 2018 Apr 14];11(1):90. Available from: http://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/1471-2474-11-90

20.

Bolland BJRF, Culliford DJ, Maskell J, Latham JM, Dunlop DG, Arden NK. The effect of hip and knee arthroplasty on oral anti-inflammatory use and the relationship to body mass index: results from the UK general practice research database. Osteoarthr Cartil [Internet]. 2011;19(1):29–36 Available from: https://doi.org/10.1016/j.joca.2010.10.012.CrossRef

21.

Singh JA, Lewallen DG. Predictors of use of pain medications for persistent knee pain after primary Total Knee Arthroplasty: a cohort study using an institutional joint registry. Arthritis Res Ther [Internet]. 2012[cited 2018 Apr 14];14(6):R248. Available from: http://arthritis-research.biomedcentral.com/articles/10.1186/ar4091 CrossRef

22.

Finnish Statistics on Medicines 2007. National Agency for Medicines (NAM) and the Social Insurance Institution (Kela). Helsinki; 2008. Available from: https://www.kela.fi/documents/12099/12170/laaketilasto07_2.pdf.

23.

Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745–59. https://doi.org/10.1016/S0140-6736(19)30417-9.CrossRef

24.

Liu A, Kendzerska T, Stanaitis I, Hawker G. The relationship between knee pain characteristics and symptom state acceptability in people with knee osteoarthritis. Osteoarthr Cartil [Internet]. 2014;22(2):178–83 Available from: https://doi.org/10.1016/j.joca.2013.11.012.CrossRef

25.

Fillingim RB, King CD, Ribeiro-Dasilva MC, Riley JL III. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain [Internet]. 2009;10(5):447–85 Available from: http://www.sciencedirect.com/science/article/pii/S1526590008009097.CrossRef

26.

Lavand’homme P, Thienpont E. Pain after total knee arthroplasty: a narrative review focusing on the stratification of patients at risk for persistent pain. Bone Joint J [Internet]. 2015[cited 2017 Jan 23];97–B(10 Suppl A):45–48. Available from: http://www.bjj.boneandjoint.org.uk/cgi/doi/10.1302/0301-620X.97B10.36524 CrossRef

27.

Lewis GN, Rice DA, McNair PJ, Kluger M. Predictors of persistent pain after total knee arthroplasty: a systematic review and meta-analysis. Br J Anaesth. 2015;114(4):551–61.CrossRef

28.

Dall GF, Ohly NE, Ballantyne JA, Brenkel IJ. The influence of pre-operative factors on the length of in-patient stay following primary total hip replacement for osteoarthritis. J Bone Joint Surg Br [Internet]. 2009;91–B(4):434–40 Available from: http://online.boneandjoint.org.uk/doi/10.1302/0301-620X.91B4.21505.CrossRef

29.

Berger A, Bozic K, Stacey B, Edelsberg J, Sadosky A, Oster G. Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum. 2011;63(8):2268–75.CrossRef

30.

Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin C-WC, Day RO, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ [Internet]. 2015;350(mar31 2):h1225 Available from: http://www.bmj.com/cgi/doi/10.1136/bmj.h1225.CrossRef

31.

Ennis ZN, Dideriksen D, Vaegter HB, Handberg G, Pottegård A. Acetaminophen for chronic pain: a systematic review on efficacy. Basic Clin Pharmacol Toxicol [Internet]. 2016;118(3):184–9 Available from: http://doi.wiley.com/10.1111/bcpt.12527.CrossRef

32.

da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet [Internet]. 2017;390(10090):e21–33 Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673617317440.CrossRef

33.

Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A Comprehesive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143–50.CrossRef

34.

Franklin PD, Karbassi JA, Li W, Yang W, Ayers DC. Reduction in narcotic use after primary total knee arthroplasty and association with patient pain relief and satisfaction. J Arthroplasty [Internet]. 2010;25(6 Suppl):12–6 Available from: http://linkinghub.elsevier.com/retrieve/pii/S0883540310002950.CrossRef

35.

Official Statistics of Finland: available at http://raportit.kela.fi/ibi_apps/WFServlet. Accessed on Aug 2 2019.

36.

Muller AE, Clausen T, Sjogren P, Odsbu I, Skurtveit S. Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017. Scand J Pain. 2019;19(2):345–53.CrossRef

37.

Centers for Disease Control and Prevention. 2018 Annual surveillance report of drug-related risks and outcomes — United States. Surveillance special report 2. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Publis.

38.

Hamunen K, Paakkari P, Kalso E. Trends in opioid consumption in the Nordic countries 2002–2006. Eur J Pain [Internet]. 2009;13(9):954–62 Available from: https://doi.org/10.1016/j.ejpain.2008.11.006.CrossRef

39.

Thorlund JB, Turkiewicz A, Prieto-alhambra D, Englund M. Opioid use in knee or hip osteoarthritis : a region-wide population- based cohort study. 2019;27(6):871–7. https://doi.org/10.1016/j.joca.2019.01.005.CrossRef

40.

Dimitroulas T, Duarte RV, Behura A, Kitas GD, Raphael JH. Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment. Semin Arthritis Rheum [Internet]. 2014;44(2):145–54 Available from: http://linkinghub.elsevier.com/retrieve/pii/S004901721400105X.CrossRef

41.

Perrot S. Targeting pain or osteoarthritis? Implications. PAIN Clin Updat [Internet]. 2016;24(2):1–8 Available from: https://www.iasp-pain.org/files/Content/ContentFolders/Publications2/PainClinicalUpdates/PCU24-2.Perrot.WebFINALpdf.pdf.

42.

Petersen KK, Arendt-Nielsen L. Chronic postoperative pain after joint replacement. Pain. 2016;24(3):1–6.

Title: Use of prescription analgesic drugs before and after hip or knee replacement in patients with osteoarthritis
Authors: Tuomas J. Rajamäki Jr
Pia A. Puolakka
Aki Hietaharju
Teemu Moilanen
Esa Jämsen
Publication date: 01-12-2019
Publisher: BioMed Central
Keywords: Osteoarthrosis
Neuropathic Pain
Paracetamol
Opioids
Opioids
Osteoarthrosis
Analgesics in Dentistry
Published in: BMC Musculoskeletal Disorders / Issue 1/2019
Electronic ISSN: 1471-2474
DOI: https://doi.org/10.1186/s12891-019-2809-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Use of prescription analgesic drugs before and after hip or knee replacement in patients with osteoarthritis

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2019

Treatment of open tibial diaphyseal fractures by external fixation combined with limited internal fixation versus simple external fixation: a retrospective cohort study

Unusual localization and presentation of osteoid osteoma mimicking juvenile spondyloarthritis: a case report

Camptocormia as the presenting symptom in sporadic late onset nemaline myopathy: a case report

Superselective angiography of the wrist in patients with Kienböck’s disease

Evaluation of the Constant score: which is the method to assess the objective strength?

Percutaneous full-endoscopic anterior transcorporeal cervical discectomy and channel repair: a technique note report